Literature DB >> 18392005

Drug makers chase cancer stem cells.

Charlie Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18392005     DOI： 10.1038/nbt0408-366c

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation.

Authors:  Julie M Hall; Melissa A Barhoover; Dmitri Kazmin; Donald P McDonnell; William F Greenlee; Russell S Thomas
Journal:  Mol Endocrinol       Date:  2009-12-23

2.  Factors influencing the abundance of the side population in a human myeloma cell line.

Authors:  Sui-Lin Mo; Jia Li; Yen S Loh; Ross D Brown; Adrian L Smith; Yuling Chen; Douglas Joshua; Basil D Roufogalis; George Q Li; Kei Fan; Michelle C H Ng; Daniel Man-Yuen Sze
Journal:  Bone Marrow Res       Date:  2011-09-22

3.  A simple mathematical model based on the cancer stem cell hypothesis suggests kinetic commonalities in solid tumor growth.

Authors:  Rodolfo Molina-Peña; Mario Moisés Álvarez
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.